Results 231 to 240 of about 14,917 (240)

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Fadlo R Khuri
exaly  

Novel Agents on the Horizon for Cancer Therapy

Ca-A Cancer Journal for Clinicians, 2009
exaly  

Do hypomethylating agents prevent relapse after Allo-HCT?

Advances in Cell and Gene Therapy, 2018
Thomas Schroeder, Christina Rautenberg, Rainer Haas, Ulrich Germing, Guido Kobbe   +4 more
openaire   +1 more source

Results of Treatment With Hypomethylating Agents Versus Hypomethylating Agents/Venetoclax in Patients With AML Single-Center Experience

Clinical Lymphoma Myeloma and Leukemia
Ana Flavia Patiño, Erika Brulc, Alberto Gimenez Conca   +2 more
openaire   +1 more source

Targeting Apoptosis Pathways in Cancer Therapy

Ca-A Cancer Journal for Clinicians, 2005
exaly  

Hypomethylating agents in myelodysplastic syndromes.

Clinical advances in hematology & oncology : H&O, 2012
openaire   +1 more source

Understanding, recognizing, and managing toxicities of targeted anticancer therapies

Ca-A Cancer Journal for Clinicians, 2013
exaly  

Chronic Inflammation: A Common and Important Factor in the Pathogenesis of Neoplasia

Ca-A Cancer Journal for Clinicians, 2006
exaly  

Lymphedema: A primer on the identification and management of a chronic condition in oncologic treatment

Ca-A Cancer Journal for Clinicians, 2009
exaly  

AML-032 Results of Treatment With Hypomethylating Agents Versus Hypomethylating Agents/Venetoclax in Patients With AML Single-Center Experience

Clinical Lymphoma Myeloma and Leukemia
Ana Flavia Patiño, Erika Brulc, Alberto Gimenez Conca   +2 more
openaire   +1 more source